Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update)
- PMID: 20167518
- PMCID: PMC4568122
- DOI: 10.1016/j.bcmd.2010.01.009
Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update)
Abstract
Chronic granulomatous Disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. The disease is caused by mutations in the genes encoding the components of the leukocyte NADPH oxidase. This enzyme produces superoxide, which is essential in the process of intracellular pathogen killing by phagocytic leukocytes. Four of the five genes involved in CGD are autosomal; these are CYBA, encoding p22-phox, NCF2, encoding p67-phox, NCF1, encoding p47-phox, and NCF4, encoding p40-phox. This article lists all mutations identified in these genes in the autosomal forms of CGD. Moreover, polymorphisms in these genes are also given, which should facilitate the recognition of future disease-causing mutations.
Figures

Similar articles
-
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).Blood Cells Mol Dis. 2021 Dec;92:102596. doi: 10.1016/j.bcmd.2021.102596. Epub 2021 Jul 28. Blood Cells Mol Dis. 2021. PMID: 34547651
-
A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.Blood. 2009 Oct 8;114(15):3309-15. doi: 10.1182/blood-2009-07-231498. Epub 2009 Aug 19. Blood. 2009. PMID: 19692703 Free PMC article.
-
Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.Hum Genet. 1999 Nov;105(5):460-7. doi: 10.1007/s004390051131. Hum Genet. 1999. PMID: 10598813
-
Hematologically important mutations: X-linked chronic granulomatous disease (third update).Blood Cells Mol Dis. 2010 Oct 15;45(3):246-65. doi: 10.1016/j.bcmd.2010.07.012. Epub 2010 Aug 21. Blood Cells Mol Dis. 2010. PMID: 20729109 Free PMC article. Review.
-
Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.Pediatr Allergy Immunol. 2016 May;27(3):242-53. doi: 10.1111/pai.12527. Epub 2016 Jan 21. Pediatr Allergy Immunol. 2016. PMID: 26680691 Review.
Cited by
-
Functional and genetic characterization of two extremely rare cases of Williams-Beuren syndrome associated with chronic granulomatous disease.Eur J Hum Genet. 2013 Oct;21(10):1079-84. doi: 10.1038/ejhg.2012.310. Epub 2013 Jan 23. Eur J Hum Genet. 2013. PMID: 23340515 Free PMC article.
-
Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease.Korean J Pediatr. 2016 Apr;59(4):196-201. doi: 10.3345/kjp.2016.59.4.196. Epub 2016 Apr 30. Korean J Pediatr. 2016. PMID: 27186231 Free PMC article.
-
Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease.J Clin Immunol. 2020 Apr;40(3):475-493. doi: 10.1007/s10875-020-00750-5. Epub 2020 Feb 10. J Clin Immunol. 2020. PMID: 32040803
-
NADPH Oxidase Deficiency: A Multisystem Approach.Oxid Med Cell Longev. 2017;2017:4590127. doi: 10.1155/2017/4590127. Epub 2017 Dec 21. Oxid Med Cell Longev. 2017. PMID: 29430280 Free PMC article. Review.
-
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.Mol Ther. 2014 Aug;22(8):1472-1483. doi: 10.1038/mt.2014.87. Epub 2014 May 29. Mol Ther. 2014. PMID: 24869932 Free PMC article.
References
-
- Iwata M, Nunoi H, Yamazaki H, Nakano T, Niwa H, Tsuruta S, Ohga S, Ohmi S, Kanegasaki S, Matsuda I. Homologous dinucleotide (GT or TG) deletion in Japanese patients with chronic granulomatous disease with p47-phox deficiency. Biochem Biophys Res Commun. 1994;199:1372–1377. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases